Innophos Holdings Stock Current Liabilities
Innophos Holdings fundamentals help investors to digest information that contributes to Innophos Holdings' financial success or failures. It also enables traders to predict the movement of Innophos Stock. The fundamental analysis module provides a way to measure Innophos Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innophos Holdings stock.
Innophos |
Innophos Holdings Company Current Liabilities Analysis
Innophos Holdings' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Innophos Holdings Current Liabilities | 104.1 M |
Most of Innophos Holdings' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innophos Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Innophos Holdings has a Current Liabilities of 104.1 M. This is 98.32% lower than that of the Basic Materials sector and 87.61% lower than that of the Specialty Chemicals industry. The current liabilities for all United States stocks is 98.68% higher than that of the company.
Innophos Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innophos Holdings' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Innophos Holdings could also be used in its relative valuation, which is a method of valuing Innophos Holdings by comparing valuation metrics of similar companies.Innophos Holdings is currently under evaluation in current liabilities category among related companies.
Innophos Fundamentals
| Return On Equity | 0.0014 | |||
| Return On Asset | 7.0E-4 | |||
| Profit Margin | 0.0006 % | |||
| Operating Margin | 14.40 % | |||
| Current Valuation | 993.69 M | |||
| Shares Outstanding | 19.69 M | |||
| Shares Owned By Insiders | 1.36 % | |||
| Shares Owned By Institutions | 98.64 % | |||
| Number Of Shares Shorted | 187.27 K | |||
| Price To Earning | 29.65 X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 758.54 M | |||
| Gross Profit | 153.09 M | |||
| EBITDA | 85.06 M | |||
| Net Income | 21.27 M | |||
| Cash And Equivalents | 30.73 M | |||
| Cash Per Share | 0.80 X | |||
| Total Debt | 399.86 M | |||
| Debt To Equity | 118.30 % | |||
| Current Ratio | 2.94 X | |||
| Book Value Per Share | 20.78 X | |||
| Cash Flow From Operations | 62.91 M | |||
| Short Ratio | 1.02 X | |||
| Earnings Per Share | 1.08 X | |||
| Price To Earnings To Growth | 1.45 X | |||
| Number Of Employees | 1.49 K | |||
| Beta | 1.57 | |||
| Market Capitalization | 629.91 M | |||
| Total Asset | 668.22 M | |||
| Retained Earnings | 418.67 M | |||
| Working Capital | 189.72 M | |||
| Current Asset | 293.83 M | |||
| Current Liabilities | 104.1 M | |||
| Z Score | 1.6 | |||
| Five Year Return | 4.94 % | |||
| Last Dividend Paid | 0.48 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Innophos Stock
If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |